logo
 
Taking ibuprofen and aspirin can triple the likelihood of surviving cancer, a new study suggests.

A trial at the University of California found the five-year survival rate of 25 per cent increased to 78 per cent when  some patients took the anti-inflammatory medications.

The drug’s apparently dramatic beneficial effect applied to patients with an alteration to a particular gene in their cancerous tumour, known as PIK3CA.

The scientists behind the research say this is significant because that gene alteration occurs across a range of different cancers, including breast, bowel and endometrial cancer.

It means that, once backed up by larger trials, prescribing non-steroidal anti-inflammatory drugs.

No Comments For This Post, Be first to write a Comment.
Leave a Comment
Name:
Email:
Comment:
Enter the code shown:


Can't read the image? click here to refresh

Todays Epaper

Do you think that India should not play against Pakistan in 2019 Cricket World Cup after Pulwama attack?

Yes
No
Can't Say